Beta Drugs Ltd Q1 FY2026-2027 Results: Summary
Revenue | ₹127.13Cr |
Net Profits | ₹15.80Cr |
Net Profit Margins | 12.43% |
Beta Drugs Ltd’s revenue jumped 23.2% since last year same period to ₹127.13Cr in the Q1 2026-2027. On a quarterly growth basis, Beta Drugs Ltd has generated 31.25% jump in its revenue since last 3-months.
Beta Drugs Ltd’s net profit jumped 35.04% since last year same period to ₹15.80Cr in the Q1 2026-2027. On a quarterly growth basis, Beta Drugs Ltd has generated 74.59% jump in its net profits since last 3-months.
Beta Drugs Ltd’s net profit margin jumped 9.61% since last year same period to 12.43% in the Q1 2026-2027. On a quarterly growth basis, Beta Drugs Ltd has generated 33.02% jumped in its net profit margins since last 3-months.
FAQs
What was the revenue for Beta Drugs Ltd in Q1 results 2026?
The revenue for Beta Drugs Ltd in the Q1 results 2026 was ₹127.13Cr.
What was the net profit for Beta Drugs Ltd in Q1 results 2026?
The net profit for Beta Drugs Ltd in the Q1 results 2026 was ₹15.80Cr.
What was the net profit margin for Beta Drugs Ltd in Q1 results 2026?
The net profit margin for Beta Drugs Ltd in the Q1 results 2026 was 12.43%.
What was the revenue for Beta Drugs Ltd in Q1 results 2025?
The revenue for Beta Drugs Ltd in the Q1 results 2025 was ₹103.19Cr.
What was the net profit for Beta Drugs Ltd in Q1 results 2025?
The net profit for Beta Drugs Ltd in the Q1 results 2025 was ₹11.70Cr.
What was the net profit margin for Beta Drugs Ltd in Q1 results 2025?
The net profit margin for Beta Drugs Ltd in the Q1 results 2025 was 11.34%.
